BA
AVNS

Broadview Advisors’s Avanos Medical AVNS Stock Holding History

Broadview Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$5.4M Buy
123,838
+76,188
+160% +$3.26M 1.67% 25
2019
Q1 		$2.03M Buy
+47,650
New +$2.13M 0.55% 59

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Broadview Advisors's AVNS Position: Q2 2019 in Review

Broadview Advisors increased its Avanos Medical (AVNS) stake by 160% in Q2 2019, buying an estimated $3.26M and bringing the position to 123,838 shares worth $5.4M. The position accounts for 1.67% of the portfolio, ranked #25.

Broadview Advisors first reported a position in AVNS in Q1 2019 and has held it in 2 quarters since. 317 funds tracked by Wall St. Rank hold AVNS as of Q2 2019.

  • Broadview Advisors held 123,838 shares of Avanos Medical worth $5.4M as of Q2 2019.
  • Broadview Advisors bought 76,188 Avanos Medical shares in Q2 2019, an estimated $3.26M.
  • Avanos Medical made up 1.67% of Broadview Advisors's portfolio in Q2 2019, its #25 holding.
  • Broadview Advisors first reported a position in Avanos Medical in Q1 2019 and has held it in 2 quarters since.
  • 317 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2019.

Based on Broadview Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.